According to Artiva Biotherapeutics's latest financial reports the company's current EPS (TTM) is -4,67ย โฌ. In 2023 the company made an earnings per share (EPS) of -1,51ย โฌ an increase over its 2022 EPS that were of -3,19ย โฌ.